Interconnection between biological abnormalities in borderline personality disorder: Use of the Bayesian networks model

Psychiatry Research

Volumn 186, Issue 2-3, 2011, Pages 315-319

  De la Fuente, José Manuel ^a,b   Bengoetxea, Endika ^c   Navarro, Felipe ^d   Bobes, Julio ^b   Alarcón, Renato Daniel ^e  

^a Hopital Psychiatrique de Lannemezan   (France)

^b UNIVERSITY OF OVIEDO   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^e Mayo Clinic College of Medicine   (United States)

Author keywords

Bayesian networks; Biological objectivity; Borderline personality disorder; Psychiatric diagnosis and classification

Indexed keywords

HYDROCORTISONE; THYROTROPIN;

ADULT; ARTICLE; ARTIFICIAL INTELLIGENCE; BAYES THEOREM; BORDERLINE STATE; CLINICAL ARTICLE; CLINICAL NEUROLOGIC SOFT SIGNS; DEXAMETHASONE SUPPRESSION TEST; EEG ABNORMALITY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTIRELIN TEST; PSYCHIATRIC DIAGNOSIS; REM SLEEP; SLEEP PARAMETERS; SLOW WAVE SLEEP; SYMPTOM;

ADULT; ARTIFICIAL INTELLIGENCE; BAYES THEOREM; BORDERLINE PERSONALITY DISORDER; DEXAMETHASONE; ELECTROENCEPHALOGRAPHY; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; SLEEP DISORDERS; THYROTROPIN-RELEASING HORMONE; YOUNG ADULT;

EID: 79952359672     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.08.027     Document Type: Article

References (55)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R), revised 1987, American Psychiatric Association, Washington, DC. 3rd ed.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 1994, American Psychiatric Association, Washington, DC. 4th edition ed.
3. Antal P., Fannes G., Timmerman D., Moreau Y.De., Moor B. Bayesian applications of belief networks and multilayer perceptrons for ovarian tumor classification with rejection. Artificial Intelligence in Medicine 2003, 29(1-2):39-60.
4. Asaad T., Okasha T., Okasha A. Sleep EEG findings in ICD-10 borderline personality disorder in Egypt. Journal of Affective Disorders 2002, 71(1-3):11-18.
5. Bastien C.H., Guimond S., St-Jean G., Lemelin S. Signs of insomnia in borderline personality disorder individuals. Journal of Clinical Sleep Medicine 2008, 4(5):462-470.
6. Battaglia M., Ferini-Strambi L., Smirne S., Bernardeschi L., Bellodi L. Ambulatory polysomnography of never-depressed borderline subjects: a high-risk approach to rapid eye movement latency. Biological Psychiatry 1993, 33(5):326-334.
7. Battaglia M., Ferini Strambi L., Bertella S., Bajo S., Bellodi L. First-cycle REM density in never-depressed subjects with borderline personality disorder. Biological Psychiatry 1999, 45(8):1056-1058.
8. Bengoetxea E., Larrañaga P., Bloch I., Perchant A., Boeres C. Learning and simulation of Bayesian networks applied to inexact graph matching. Pattern Recognition 2002, 35:2867-2880.
9. Benson K.L., King R., Gordon D., Silva J.A., Zarcone V.P. Sleep patterns in borderline personality disorder. Journal of Affective Disorders 1990, 18(4):267-273.
10. Boutros N.N., Torello M., McGlashan T.H. Electrophysiological aberrations in borderline personality disorder: state of the evidence. The Journal of Neuropsychiatry and Clinical Neurosciences 2003, 15(2):145-154.
11. Cooper G.F., Herskovits E. A Bayesian method for the introduction of probabilistic networks from data. Machine Learning 1992, 9:309-347.
12. Cowdry R.W., Pickar D., Davies R. Symptoms and EEG findings in the borderline syndrome. International Journal of Psychiatry in Medicine 1985, 15(3):201-211.
13. De la Fuente J.M., Mendlewicz J. TRH stimulation and dexamethasone suppression in borderline personality disorder. Biological Psychiatry 1996, 40(5):412-418.
14. De La Fuente J.M., Goldman S., Stanus E., Vizuete C., Morlan I., Bobes J., Mendlewicz J. Brain glucose metabolism in borderline personality disorder. Journal of Psychiatric Research 1997, 31(5):531-541.
15. De la Fuente J.M., Tugendhaft P., Mavroudakis N. Electroencephalographic abnormalities in borderline personality disorder. Psychiatry Research 1998, 77(2):131-138.
16. De la Fuente J.M., Bobes J., Vizuete C., Mendlewicz J. Sleep-EEG in borderline patients without concomitant major depression: a comparison with major depressives and normal control subjects. Psychiatry Research 2001, 105(1-2):87-95.
17. De la Fuente J.M., Bobes J., Vizuete C., Mendlewicz J. Biological nature of depressive symptoms in borderline personality disorder: endocrine comparison to recurrent brief and major depression. Journal of Psychiatric Research 2002, 36(3):137-145.
18. De la Fuente J.M., Bobes J., Morlan I., Bascaran M.T., Vizuete C., Linkowski P., Mendlewicz J. Is the biological nature of depressive symptoms in borderline patients without concomitant Axis I pathology idiosyncratic? Sleep EEG comparison with recurrent brief, major depression and control subjects. Psychiatry Research 2004, 129(1):65-73.
19. De la Fuente J.M., Bobes J., Vizuete C., Bascaran M.T., Morlan I., Mendlewicz J. Neurologic soft signs in borderline personality disorder. The Journal of Clinical Psychiatry 2006, 67(4):541-546.
20. Endicott J., Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 1978, 35(7):837-844.
21. Gardner D., Lucas P.B., Cowdry R.W. Soft sign neurological abnormalities in borderline personality disorder and normal control subjects. The Journal of Nervous and Mental Disease 1987, 175(3):177-180.
22. Gunderson J.G., Kolb J.E., Austin V. The diagnostic interview for borderline patients. The American Journal of Psychiatry 1981, 138(7):896-903.
23. Gunderson J.G., Morey L.C., Stout R.L., Skodol A.E., Shea M.T., McGlashan T.H., Zanarini M.C., Grilo C.M., Sanislow C.A., Yen S., Daversa M.T., Bender D.S. Major depressive disorder and borderline personality disorder revisited: longitudinal interactions. The Journal of Clinical Psychiatry 2004, 65(8):1049-1056.
24. Gunderson J.G., Daversa M.T., Grilo C.M., McGlashan T.H., Zanarini M.C., Shea M.T., Skodol A.E., Yen S., Sanislow C.A., Bender D.S., Dyck I.R., Morey L.C., Stout R.L. Predictors of 2-year outcome for patients with borderline personality disorder. The American Journal of Psychiatry 2006, 163(5):822-826.
25. Heckerman D., Geiger D. Learning Bayesian networks: the combination of knowledge and statistical data. Machine Learning 1995, 20:197-243.
26. Heckerman D., Wellman M.P. Bayesian networks. Communications of the ACM 1995, 38:27-30.
27. Howard R., Matheson J. Influence diagrams. Readings on the principles and applications of decision analysis strategic decision group, Menlo Park, California 1981, 721-764. Vol. 2. R. Howard, J. Matheson (Eds.).
28. Kemp C., Perfors A., Tenenbaum J.B. Learning overhypotheses with hierarchical Bayesian models. Developmental Science 2007, 10(3):307-321.
29. Kolb J.E., Gunderson J.G. Diagnosing borderline patients with a semistructured interview. Archives of General Psychiatry 1980, 37(1):37-41.
30. Korzekwa M., Steiner M., Links P., Eppel A. The dexamethasone suppression test in borderlines: is it useful?. Canadian Journal of Psychiatry 1991, 36(1):26-28.
31. Lahmeyer H.W., Val E., Gaviria F.M., Prasad R.B., Pandey G.N., Rodgers P., Weiler M.A., Altman E.G. EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder. Psychiatry Research 1988, 25(1):19-30.
32. Lange W., Wulff H., Berea C., Beblo T., Saavedra A.S., Mensebach C., Wingenfeld K., Driessen M. Dexamethasone suppression test in borderline personality disorder-effects of posttraumatic stress disorder. Psychoneuroendocrinology 2005, 30(9):919-923.
33. Lauritzen S.L. Graphical Models 1996, Oxford University Press, Oxford.
34. Mani S., McDermott S. Building Bayesian network models in medicine: the MENTOR experience. Applied Intelligence 2005, 22:93-108.
35. Pang B., Zhang D., Li N., Wang K. Computerized tongue diagnosis based on Bayesian networks. IEEE Transactions on Biomedical Engineering 2004, 51(10):1803-1810.
36. Pearl J. Reasoning in Intelligent Systems 1988, Morgan Kaufmann, Palo Alto, California.
37. Philipsen A., Feige B., Al-Shajlawi A., Schmahl C., Bohus M., Richter H., Voderholzer U., Lieb K., Riemann D. Increased delta power and discrepancies in objective and subjective sleep measurements in borderline personality disorder. Journal of Psychiatric Research 2005, 39(5):489-498.
38. Pope H.G., Jonas J.M., Hudson J.I., Cohen B.M., Gunderson J.G. The validity of DSM-III borderline personality disorder. A phenomenologic, family history, treatment response, and long-term follow-up study. Archives of General Psychiatry 1983, 40(1):23-30.
39. Sadeghi S., Barzi A., Sadeghi N., King B. A Bayesian model for triage decision support. International Journal of Medical Informatics 2006, 75(5):403-411.
40. Schultz P.M., Soloff P.H., Kelly T., MOrgenstern M., Di Franco R., Schultz S.C. A family study of borderline subtypes. Journal of Personality Disorders 1989, 3:217-229.
41. Shultz T.R. The Bayesian revolution approaches psychological development. Developmental Science 2007, 10(3):357-364.
42. Skodol A.E., Gunderson J.G., Pfohl B., Widiger T.A., Livesley W.J., Siever L.J. The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biological Psychiatry 2002, 51(12):936-950.
43. Skodol A.E., Siever L.J., Livesley W.J., Gunderson J.G., Pfohl B., Widiger T.A. The borderline diagnosis II: biology, genetics, and clinical course. Biological Psychiatry 2002, 51(12):951-963.
44. Skodol A.E., Gunderson J.G., Shea M.T., McGlashan T.H., Morey L.C., Sanislow C.A., Bender D.S., Grilo C.M., Zanarini M.C., Yen S., Pagano M.E., Stout R.L. The Collaborative Longitudinal Personality Disorders Study (CLPS): overview and implications. Journal of Personality Disorders 2005, 19(5):487-504.
45. Snyder S., Pitts W.M. Electroencephalography of DSM-III borderline personality disorder. Acta Psychiatrica Scandinavica 1984, 69(2):129-134.
46. Spitzer R.L., Endicott J., Robins E. Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry 1978, 35(6):773-782.
47. Stein D.J., Hollander E., Cohen L., Frenkel M., Saoud J.B., DeCaria C., Aronowitz B., Levin A., Liebowitz M.R., Cohen L. Neuropsychiatric impairment in impulsive personality disorders. Psychiatry Research 1993, 48(3):257-266.
48. Stern A. Psychoanalytic investigation and therapy in the borderline group of neuroses. The Psychoanalytic Quarterly 1938, 7:467-489.
49. Tanahashi Y. Electroencephalographic studies of borderline personality disorder. Juntendoigaku 1988, 34:207-219.
50. Visscher S., Lucas P., Bonten M. Improving the therapeutic performance of a medical Bayesian network using noisy threshold models. Lecture Notes in Computer Science 2005, 3745:161-172.
51. Wang D., Lertsithichai P., Nanchahal K., Yousufuddin M. Risk factors of coronary heart disease: a Bayesian model averaging approach. Journal of Applied Statistics 2003, 30:813-826.
52. Witten I.H., Frank E. Data mining: practical machine learning tools and techniques 2005, Morgan Kaufman, Hamilton, New Zealand. 2nd ed.
53. World Health Organization The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines 1992, World Health Organization, Geneva.
54. Xu F., Tenenbaum J.B. Sensitivity to sampling in Bayesian word learning. Developmental Science 2007, 10(3):288-297.
55. Zanarini M.C., Frankenburg F.R., Hennen J., Reich D.B., Silk K.R. Prediction of the 10-year course of borderline personality disorder. The American Journal of Psychiatry 2006, 163(5):827-832.